Measurement of opioid misuse in the general Mexican population: Encodat 2025
Salud Pública de México · 30.07.2026 · 68 (4 (jul-ago)) · 342-347
DOI: 10.21149/18189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Salud Pública de México, online erschienen am 30.07.2026. Verfasst von Andrés Sánchez-Pájaro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico. Center for Opioid Epidemiology and Po…. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Prescription Drug Misuse. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Objective
To examine the prevalence of categorical self-reported opioid misuse and compare it to a post hoc corrected indicator in the general Mexican population. Materials and methods. We used data from the 2025 Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco. We constructed indicators from self-reported categorical heroin/fentanyl use, prescription opioids misuse and opioid misuse and post hoc corrected versions based on the review of open-ended follow up questions by two experts. We estimated the prevalence from categorical self-report responses and compared it with the post hoc corrected indicators.
Results
The prevalence of self-reported prescription opioid misuse was 1 948.3 per 100 000 people, which decreased to 1 242.4 after correction. Self-reported heroin or fentanyl use was 370.7 per 100 000 people, with a corrected prevalence of 326.2. Self-reported opioid misuse had a prevalence of 2 229.6 per 100 000 people, which decreased to 1 482.3 after correction.
Conclusion
Misclassification was more frequent for prescription opioid misuse than for illicit opioid use. Simple categorical questions performed well for measuring illicit opioid use, but they moderately overestimated prescription and overall opioid misuse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico. Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine…
- Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine. New York, United States.. alambertocdc@gmail.com.
- Center for Opioid Epidemiology and Policy, Department of Population Health, NYU Grossman School of Medicine. New York, United States.. ariadne.rivera@nyulangone.org.
- Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, Mexico.. maria.rivero@insp.edu.mx.
- Centro de Investigación y de Estudios Avanzados, Departamento de Farmacobiología, Instituto Politécnico Nacional. Mexico City, Mexico.. slcruzm@cinvestav.mx.
- Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Mexico City, Mexico.. miguel.lobram@gmail.com.
Zitieren
APA
Sánchez-Pájaro, A., Reyes-García, A., Rivera-Aguirre, A., Rivero-Treviño, M. J., Cruz, S. L., López-Brambila, M. Á., Pech-Puebla, D., & Cerdá, M. (2026). Measurement of opioid misuse in the general Mexican population: Encodat 2025. Salud Pública de México, 68(4 (jul-ago)), 342-347. https://doi.org/10.21149/18189
Vancouver
Sánchez-Pájaro A, Reyes-García A, Rivera-Aguirre A, Rivero-Treviño MJ, Cruz SL, López-Brambila MÁ, et al. Measurement of opioid misuse in the general Mexican population: Encodat 2025. Salud Pública de México. 2026;68(4 (jul-ago)):342-347. doi:10.21149/18189
BibTeX
@article{SnchezPjaro2026,
author = {Sánchez-Pájaro, Andrés and Reyes-García, Alan and Rivera-Aguirre, Ariadne and Rivero-Treviño, María José and Cruz, Silvia L and López-Brambila, Miguel Ángel and Pech-Puebla, Daniel and Cerdá, Magdalena},
title = {Measurement of opioid misuse in the general Mexican population: Encodat 2025},
journal = {Salud Pública de México},
year = {2026},
volume = {68},
number = {4 (jul-ago)},
pages = {342--347},
doi = {10.21149/18189}
}
EUVIMED